| Literature DB >> 29535699 |
Petra Schwendner1, Maria Bohmeier2, Petra Rettberg2, Kristina Beblo-Vranesevic2, Frédéric Gaboyer3, Christine Moissl-Eichinger4,5, Alexandra K Perras4,6, Pauline Vannier7, Viggó T Marteinsson7,8, Laura Garcia-Descalzo9, Felipe Gómez9, Moustafa Malki10, Ricardo Amils10, Frances Westall3, Andreas Riedo11, Euan P Monaghan11, Pascale Ehrenfreund11,12, Patricia Cabezas12,13, Nicolas Walter12,13, Charles Cockell1.
Abstract
Growth in sodium chloride (NaCl) is known to induce stress in non-halophilic microorganisms leading to effects on the microbial metabolism and cell structure. Microorganisms have evolved a number of adaptations, both structural and metabolic, to counteract osmotic stress. These strategies are well-understood for organisms in NaCl-rich brines such as the accumulation of certain organic solutes (known as either compatible solutes or osmolytes). Less well studied are responses to ionic environments such as sulfate-rich brines which are prevalent on Earth but can also be found on Mars. In this paper, we investigated the global metabolic response of the anaerobic bacterium Yersinia intermedia MASE-LG-1 to osmotic salt stress induced by either magnesium sulfate (MgSO4) or NaCl at the same water activity (0.975). Using a non-targeted mass spectrometry approach, the intensity of hundreds of metabolites was measured. The compatible solutes L-asparagine and sucrose were found to be increased in both MgSO4 and NaCl compared to the control sample, suggesting a similar osmotic response to different ionic environments. We were able to demonstrate that Yersinia intermedia MASE-LG-1 accumulated a range of other compatible solutes. However, we also found the global metabolic responses, especially with regard to amino acid metabolism and carbohydrate metabolism, to be salt-specific, thus, suggesting ion-specific regulation of specific metabolic pathways.Entities:
Keywords: compatible solutes; magnesium sulfate; metabolome; sodium chloride; stress response
Year: 2018 PMID: 29535699 PMCID: PMC5835128 DOI: 10.3389/fmicb.2018.00335
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Growth curve of Y. intermedia MASE-LG-1 cultivated under the three investigated conditions applied for the metabolome experiments; optimal anoxic conditions (30°C, pH 7, 0 M NaCl, 0 M MgSO4), NaCl salt stressed (30°C, pH 7, 0.4 M NaCl) and MgSO4 salt stressed (30°C, pH 7, 0.7 M MgSO4). Growth was determined by direct cell counting. The images display the morphological change when grown in control conditions and in MgSO4.
Figure 2Volcano plots displaying significance (y-axis) vs. fold-change (x-axis). Metabolite data for Y. intermedia MASE-LG-1 grown under non-stressed conditions (control, C) and salt-stressed condition with identical water availability in NaCl and MgSO4. Pairwise comparison of (A) control and NaCl relative to control, (B) control and MgSO4 relative to control, and (C) NaCl and MgSO4 relative to NaCl. The plot is generated by plotting the negative log (base 10) of the adjusted p-value (<0.05) on the y-axis. Significant and insignificant peaks are represented by dark blue and light blue data points, respectively.
Figure 3Pie-chart representing the percentage and biological categories of the identified or putatively annotated metabolites based upon their putative functions. Assignment was performed using KEGG database. (A) Data are comprised of 385 peaks, the three smallest sections represent energy metabolism, xenobiotics drugs etc., xenobiotics biodegradation and metabolism with <1%. (B) Detailed information about the various lipid compounds. * depicts peaks of metabolites that are involved in the lipid metabolism but are grouped within a different chemical class.
KEGG pathway maps for Y. intermedia yin631.
| Metabolism | Global and overview maps | 01100 Metabolic pathways | 38 | 20 | 20 |
| 01110 Biosynthesis of secondary metabolites | 27 | 15 | 15 | ||
| 01120 Microbial metabolism in diverse environments | 21 | 12 | 11 | ||
| 01130 Biosynthesis of antibiotics | 25 | 14 | 13 | ||
| 01200 Carbon metabolism | 5 | 2 | 4 | ||
| 01210 2-Oxocarboxylic acid metabolism | 10 | 5 | 4 | ||
| 01230 Biosynthesis of amino acids | 18 | 9 | 9 | ||
| 01220 Degradation of aromatic compounds | 6 | 2 | 3 | ||
| Carbohydrate metabolism | 00010 Glycolysis / Gluconeogenesis | 1 | 1 | 1 | |
| 00020 Citrate cycle (TCA cycle) | 1 | 0 | 1 | ||
| 00030 Pentose phosphate pathway | 0 | 1 | 1 | ||
| 00040 Pentose and glucuronate interconversions | 0 | 1 | 0 | ||
| 00051 Fructose and mannose metabolism | 0 | 1 | 1 | ||
| 00052 Galactose metabolism | 1 | 2 | 1 | ||
| 00053 Ascorbate and aldarate metabolism | 1 | 2 | 3 | ||
| 00500 Starch and sucrose metabolism | 0 | 1 | 1 | ||
| 00520 Amino sugar and nucleotide sugar metabolism | 1 | 3 | 2 | ||
| 00620 Pyruvate metabolism | 1 | 0 | 1 | ||
| 00630 Glyoxylate and dicarboxylate metabolism | 5 | 1 | 3 | ||
| 00640 Propanoate metabolism | 3 | 1 | 2 | ||
| 00650 Butanoate metabolism | 3 | 0 | 3 | ||
| 00660 C5-Branched dibasic acid metabolism | 1 | 2 | 3 | ||
| 00562 Inositol phosphate metabolism | 0 | 1 | 1 | ||
| Energy metabolism | 00190 Oxidative phosphorylation | 1 | 0 | 1 | |
| 00680 Methane metabolism | 2 | 1 | 2 | ||
| 00910 Nitrogen metabolism | 2 | 0 | 1 | ||
| 00920 Sulfur metabolism | 4 | 0 | 3 | ||
| Lipid metabolism | 00061 Fatty acid biosynthesis | 2 | 2 | 0 | |
| 00071 Fatty acid degradation | 0 | 0 | 0 | ||
| 00121 Secondary bile acid biosynthesis | 0 | 0 | 0 | ||
| 00561 Glycerolipid metabolism | 1 | 0 | 0 | ||
| 00564 Glycerophospholipid metabolism | 2 | 2 | 3 | ||
| 00565 Ether lipid metabolism | 1 | 0 | 0 | ||
| 00600 Sphingolipid metabolism | 1 | 0 | 0 | ||
| 00590 Arachidonic acid metabolism | 0 | 0 | 0 | ||
| 00592 alpha-Linolenic acid metabolism | 0 | 0 | 0 | ||
| 01040 Biosynthesis of unsaturated fatty acids | 1 | 1 | 0 | ||
| Nucleotide metabolism | 00230 Purine metabolism | 8 | 4 | 4 | |
| 00240 Pyrimidine metabolism | 3 | 0 | 2 | ||
| Glycan biosynthesis and metabolism | 00540 Lipopolysaccharide biosynthesis | 0 | 0 | 0 | |
| 00550 Peptidoglycan biosynthesis | 1 | 1 | 0 | ||
| 00511 Other glycan degradation | 1 | 1 | 1 | ||
| Metabolism of cofactors and vitamins | 00730 Thiamine metabolism | 1 | 0 | 0 | |
| 00740 Riboflavin metabolism | 0 | 0 | 0 | ||
| 00750 Vitamin B6 metabolism | 0 | 0 | 0 | ||
| 00760 Nicotinate and nicotinamide metabolism | 3 | 0 | 3 | ||
| 00770 Pantothenate and CoA biosynthesis | 1 | 1 | 1 | ||
| 00780 Biotin metabolism | 2 | 1 | 0 | ||
| 00785 Lipoic acid metabolism | 0 | 0 | 0 | ||
| 00790 Folate biosynthesis | 1 | 0 | 1 | ||
| 00670 One carbon pool by folate | 0 | 0 | 0 | ||
| 00860 Porphyrin and chlorophyll metabolism | 3 | 0 | 2 | ||
| 00130 Ubiquinone and other terpenoid-quinone biosynthesis | 1 | 0 | 1 | ||
| Biosynthesis of other secondary metabolites | 00332 Carbapenem biosynthesis | 2 | 0 | 2 | |
| 00261 Monobactam biosynthesis | 3 | 1 | 2 | ||
| 00521 Streptomycin biosynthesis | 0 | 2 | 2 | ||
| 00525 Acarbose and validamycin biosynthesis | 0 | 0 | 0 | ||
| 00401 Novobiocin biosynthesis | 2 | 0 | 2 | ||
| Xenobiotics biodegradation and metabolism | 00362 Benzoate degradation | 1 | 0 | 0 | |
| 00627 Aminobenzoate degradation | 3 | 0 | 2 | ||
| 00364 Fluorobenzoate degradation | 0 | 0 | 0 | ||
| 00625 Chloroalkane and chloroalkene degradation | 2 | 2 | 2 | ||
| 00361 Chlorocyclohexane and chlorobenzene degradation | 4 | 0 | 2 | ||
| 00623 Toluene degradation | 1 | 0 | 0 | ||
| 00633 Nitrotoluene degradation | 0 | 0 | 1 | ||
| 00930 Caprolactam degradation | 1 | 1 | 0 | ||
| 00626 Naphthalene degradation | 1 | 0 | 1 | ||
| Genetic Information Processing | Transcription | 03020 RNA polymerase | 0 | 0 | 0 |
| Translation | 03010 Ribosome | 0 | 0 | 0 | |
| 00970 Aminoacyl-tRNA biosynthesis | 9 | 1 | 5 | ||
| Folding, sorting and degradation | 03060 Protein export | 0 | 0 | 0 | |
| 04122 Sulfur relay system | 1 | 0 | 1 | ||
| 03018 RNA degradation | 0 | 0 | 0 | ||
| Environmental Information Processing | Membrane transport | 02010 ABC transporters | 9 | 5 | 5 |
| 02060 Phosphotransferase system (PTS) | 2 | 2 | 1 | ||
| 03070 Bacterial secretion system | 5 | 1 | 3 | ||
| Signal transduction | 02020 Two-component system | 0 | 0 | 0 | |
| Cellular Processes | Cellular community - prokaryotes | 02024 Quorum sensing | 1 | 0 | 0 |
| Cell motility | 02030 Bacterial chemotaxis | 1 | 1 | 1 | |
| 02040 Flagellar assembly | 0 | 0 | 0 | ||
| Human Diseases | Drug resistance: Antimicrobial | 01501 beta-Lactam resistance | 0 | 0 | 0 |
| 01502 Vancomycin resistance | 2 | 1 | 0 | ||
| 01503 Cationic antimicrobial peptide (CAMP) resistance | 0 | 0 | 0 |
The numbers indicate the number of significantly changing peaks identified for each map or pathway.
Figure 4Visualization of metabolites that are significantly changed (adjusted p-value < 0.05) in the salt-stressed sample NaCl on the KEGG metabolic pathway map using Pathway Projector (Kono et al., 2009). Color code for pathway categories: aqua represents glycan biosynthesis and metabolism, blue represents carbohydrate metabolism, green represents lipid metabolism, red represents nucleotide metabolism, purple represents energy metabolism, yellow represents amino acid metabolism, pink represents metabolism of cofactors and vitamins, dark red represents biosynthesis of secondary metabolites, orange represents metabolism of other amino acids, and magenta represents biodegradation and metabolism of xenobiotics. Blue circles indicate a decrease and red circles an increase in the salt-stressed sample compared to the control. Orange circles depict metabolites only found in the salt stress sample, whereas cyan circles depict metabolites only found in the control sample. Size indicates the relative increase but is cut off at 3 due to overlay issues. Pairwise comparison of (A) control and NaCl relative to control, (B) control and MgSO4 relative to control, and (C) NaCl and MgSO4 relative to NaCl.
Figure 5Visualization of metabolites that are significantly changed (adjusted p-value < 0.05) in salt stressed sample NaCl on the KEGG global map: Biosynthesis of amino acids 01230. Green lines indicate pathways identified for yin631. Orange lines indicate pathways where metabolites have been identified. Yellow circle: putatively annotated metabolite but not significantly changed. Black circle: identified metabolite, i.e., the peak matches a standard, but is not significantly changed. Arrows indicate increase (red) or decrease (blue) in salt stress samples. Black outline of the arrows depicts an identified metabolite, while no outline indicates a putatively annotated metabolite.
Figure 6Visualization of metabolites that are significantly changed (adjusted p-value < 0.05) in salt stressed sample MgSO4 on the KEGG global map: Biosynthesis of amino acids 01230. Green lines indicate pathways identified for yin631. Orange lines indicate pathways where metabolites have been identified. Yellow circle: putatively annotated metabolite but not significantly changed. Black circle: identified metabolite, i.e. the peak matches a standard, but is not significantly changed. Arrows indicate increase (red) or decrease (blue) in salt stress samples. Black outline of the arrows depicts an identified metabolite, while no outline indicates a putatively annotated metabolite.
Figure 7Visualization of metabolites that are significantly changed (adjusted p-value < 0.05) under both salts relative to NaCl on the KEGG global map: Biosynthesis of amino acids 01230. Green lines indicate pathways identified for yin631. Orange lines indicate pathways where metabolites have been identified. Yellow circle: putatively annotated metabolite but not significantly changed. Black circle: identified metabolite, i.e., the peak matches a standard, but is not significantly changed. Arrows indicate increase (red) or decrease (blue) in MgSO4 stressed samples. Black outline of the arrows depicts an identified metabolite, while no outline indicates a putatively annotated metabolite.
List of identified osmolytes.
| L-Asparagine | C4H8N2O3 | amino acid | Alanine and aspartate metabolism; Tetracycline biosynthesis; Cyanoamino acid metabolism; Nitrogen metabolism | ||
| Glutathione | C10H17N3O6S | 1.19 | 1.66 | amino acid | Glutamate metabolism; Cysteine metabolism; Glutathione metabolism |
| L-Histidine | C6H9N3O2 | 3.49 | 1.08 | amino acid | Histidine metabolism; beta-Alanine metabolism |
| L-Proline | C5H9NO2 | 1.63 | 0.84 | amino acid | Arginine and proline metabolism; Novobiocin biosynthesis |
| L-Leucine | C6H13NO2 | 1.01 | amino acid | Valine, leucine and isoleucine degradation; Valine, leucine and isoleucine biosynthesis | |
| L-Methionine | C5H11NO2S | 1.39 | amino acid | Methionine metabolism | |
| Glycine | C2H5NO2 | 1.22 | 1.17 | amino acid | Bile acid biosynthesis; Purine metabolism; Glycine, serine and threonine metabolism; Lysine degradation; Cyanoamino acid metabolism; Glutathione metabolism; Methane metabolism; Thiamine metabolism; Porphyrin and chlorophyll metabolism; Nitrogen metabolism |
| L-Glutamate | C5H9NO4 | 1.65 | 2.10 | amino acid | Arginine and proline metabolism; Glutamate metabolism; Histidine metabolism; D-Glutamine and D-glutamate metabolism; Glutathione metabolism; Butanoate metabolism; C5-Branched dibasic acid metabolism; Porphyrin and chlorophyll metabolism; Nitrogen metabolism |
| L-Threonine | C4H9NO3 | 1.40 | 1.29 | amino acid | Glycine, serine and threonine metabolism; Valine, leucine and isoleucine biosynthesis; Porphyrin and chlorophyll metabolism |
| L-Arginine | C6H14N4O2 | 1.0 | 1.15 | amino acid | Arginine and proline metabolism; Clavulanic acid biosynthesis; D-Arginine and D-ornithine metabolism |
| 4-Aminobutanoate | C4H9NO2 | 0.36 | 0.24 | amino acid | Arginine and proline metabolism; Glutamate metabolism; beta-Alanine metabolism; Butanoate metabolism |
| L-Glutamine | C5H10N2O3 | 1.64 | amino acid | Glutamate metabolism; Purine metabolism; Pyrimidine metabolism; D-Glutamine and D-glutamate metabolism; Nitrogen metabolism | |
| Choline | C5H13NO | 0.89 | 1.17 | amino acid | Glycine, serine and threonine metabolism; Glycerophospholipid metabolism |
| L-Citrulline | C6H13N3O3 | 1.36 | 1.36 | amino acid | Arginine and proline metabolism |
| Putrescine | C4H12N2 | 2.65 | 3.53 | amino acid | Arginine and proline metabolism; Glutathione metabolism; Alkaloid biosynthesis II |
| N,N-Dimethylglycine | C4H9NO2 | 0.83 | 1.02 | amino acid | Glycine, serine and threonine metabolism |
| N6-Acetyl-L-lysine | C8H16N2O3 | 2.30 | amino acid | Lysine degradation | |
| L-Carnitine | C7H15NO3 | 1.10 | amino acid | Lysine degradation | |
| O-Acetylcarnitine | C9H17NO4 | 1.07 | amino acid | Alanine and aspartate metabolism | |
| Creatine | C4H9N3O2 | 1.57 | 1.14 | amino acid | Glycine, serine and threonine metabolism; Arginine and proline metabolism |
| L-Alanine | C3H7NO2 | 1.54 | 1.08 | amino acid | Alanine and aspartate metabolism; Cysteine metabolism; Taurine and hypotaurine metabolism; Selenoamino acid metabolism; D-Alanine metabolism; Carbon fixation; Reductive carboxylate cycle (CO2 fixation) |
| L-Aspartate | C4H7NO4 | 2.99 | 4.06 | amino acid | Alanine and aspartate metabolism; Arginine and proline metabolism; Glycine, serine and threonine metabolism; Lysine biosynthesis; Arginine and proline metabolism; Histidine metabolism; beta-Alanine metabolism; Cyanoamino acid metabolism; Carbon fixation |
| 4-Trimethyl-ammoniobutanoate | C7H15NO2 | 0.72 | amino acid | Lysine degradation | |
| Ectoine | C6H10N2O2 | 1.43 | 0.87 | amino acid | Glycine, serine and threonine metabolism |
| L-Pipecolate | C6H11NO2 | 1.51 | 0.87 | amino acid | Lysine degradation; Alkaloid biosynthesis II |
| Betaine | C5H11NO2 | amino acid | Glycine, serine and threonine metabolism | ||
| (S)-Malate | C4H6O5 | 1.47 | 1.54 | carbohydrate | Citrate cycle; Glutamate metabolism; Alanine and aspartate metabolism; Pyruvate metabolism; Glyoxylate and dicarboxylate metabolism; Carbon fixation; Reductive carboxylate cycle (CO2 fixation) |
| Sucrose | C12H22O11 | carbohydrate | Galactose metabolism; Starch and sucrose metabolism | ||
| D-Sorbitol | C6H14O6 | 1.43 | 0.12 | carbohydrate | Fructose and mannose metabolism; Galactose metabolism |
| D-Mannose | C6H12O6 | 1.33 | carbohydrate | Fructose and mannose metabolism; Galactose metabolism | |
| myo-Inositol | C6H12O6 | 1.81 | carbohydrate | Inositol metabolism; Galactose metabolism; Ascorbate and aldarate metabolism; Streptomycin biosynthesis; Inositol phosphate metabolism | |
| 1-O-Methyl-myo-inositol | C7H14O6 | 1.07 | 0.00 | carbohydrate | Inositol phosphate metabolism |
| Xylitol | C5H12O5 | 1.71 | 0.00 | carbohydrate | Pentose and glucuronate interconversions |
| (R)-3-Hydroxybutanoate | C4H8O3 | 1.41 | 1.63 | lipid | Synthesis and degradation of ketone bodies; Butanoate metabolism |
| sn-glycero-3-Phosphocholine | C8H20NO6P | 2.93 | 3.44 | lipid | Glycerophospholipid metabolism; Ether lipid metabolism |
| Taurine | C2H7NO3S | 1.37 | 0.60 | lipid | Bile acid biosynthesis; Taurine and hypotaurine metabolism |
| Stachydrine | C7H13NO2 | 0 | Stachydrine degradation | ||
Metabolite levels for each experimental group are shown. Levels are expressed as mean peak intensity relative to the mean peak intensity of the control group. Numbers indicated in bold indicates statistically significance (adjusted p-value < 0.05).
Figure 8Heatmap of detected putative osmolytes. The individual intensity values (n = 3, the numbers at the top of each column indicate the replica) of each condition, e.g., control, NaCl, and MgSO4 are shown. Metabolite levels are coloured according to relative intensity (blue = low, red = high). Asterisks mark significant different results.